As first described in retinoblastoma, tumor suppressor genes (TSG) in cancer cells are inactivated by a two-hit mechanism that is usually associated with both allelic loss and point mutation (3) . The search for loss of heterozygosity (LOH) allows for the identification of chromosomal regions that are recurrently deleted in tumors and, subsequently, for the location of candidate genes implicated in carcinogenesis (10). This method has rarely succeeded alone, but has contributed to identification of TSG alterations in tumors (3, 5, 6, 8) .
The technique is based on the comparison of polymorphic markers genotyped for both tumor and non-tumor tissues from the same patient. The most frequently used polymorphic markers are those presenting dinucleotide CA repeats (4). When a marker demonstrates a heterozygous status in normal tissues, LOH is evidenced by the observation of an allelic imbalance in tumor tissue as compared to the normal one. To refine the smallest common region of deletion in hepatocellular carcinoma on chromosome 4q (1) , an interesting case, patient CHC172, demonstrating LOH only at the D4S430 locus among 13 informative loci was further investigated.
DNA extraction was performed on Genotyping analyses were performed using the Genotyper software (both from PE Biosystems).
In the case of CHC172, non-tumor DNA exhibited a heterozygous status at locus D4S430 with the presence of two alleles of 119 and 135 bp ( Figure 1) . A dramatic reduction of the fluorescence intensity (peak height) of the smaller allele (119 bp) was observed in the tumor when compared to the larger allele (135 bp) ( Figure 1 ). Two independent PCR amplifications confirmed this result. In the three independent genotyping reactions, the quantitative allele ratio (Q-LOH) was calculated by the ratio of the fluorescence intensity of the two alleles in tumor DNA divided by the same ratio in non-tumor DNA (2,7). The Q-LOH values obtained were 0.29, 0.18 and 0.33, respectively, suggesting a contamination of the tumor sample by less than 30% of normal cells (2,9). These results were compatible with the LOH of the 119 bp allele in the tumor. As the only marker deleted on chromosome 4q was D4S430, in the case of CHC172, this chromosome deletion was further investigated.
A whole genome bacterial artificial chromosome (BAC) library constructed in the Centre d'Etude du Polymorphisme Humain (CEPH, Paris, France) with the pBELO BACII vector was screened by PCR using the D4S430 primers F and R. A BAC of 150 kb was isolated, and DNA was prepared using the QIAwell ® Kit (QIAGEN) with the procedure described by the Centre National de Sequençage (http://www. cns.fr) . Sequences of approximately 600 bp were generated using primers F and R on the BAC DNA. Alignment of the BAC sequences generated with the D4S430 Genethon sequence revealed the existence of 3 mismatches located in the 5 ′ end of the forward primer ( Figure 2 ). With these newly generated sequences, two primers, 5 (FAMTAT -
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Vol. 27, No. 6 (1999) Figure 1 . Genotyping CHC172 at the D4S430 locus. Tumor (T) and non-tumor (N) DNAs of case CHC172 were amplified with D4S430 primers forward (F) and reverse (R) (F-R), D4S430 primer F and primer 6 (F-6), primer 5 and D4S430 primer R (5-R) and with primer 5 and 6 (5-6). Under each peak, the size of alleles (bp) is indicated on the upper box, and the intensity of fluorescence is indicated on the lower box. An LOH is observed when D4S430 primer F is used in the PCR with a dramatic decrease of the fluorescent intensity of the smaller allele.
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TATGCTACAGGAACATTC) and 6 (AAGTGCGAAACTCTGTCTC), external to D4S430 forward and reverse primers, respectively, were designed ( Figure 2 ) and used to amplify a PCR fragment of 325 bp from CHC172 tumor and non-tumor DNA.
In normal DNA, the sequence of the PCR fragment encompassing D4S430 was identical to the sequence generated with the BAC DNA. In contrast, a heterozygous mutation located in the sequence complementary to the primer F was evidenced in the tumor sample ( Figure 2) . The somatic mutation observed in CHC172 tumor DNA added a fourth mismatch with the D4S430 forward primer sequence. The hypothesis to explain the false positive LOH with D4S430 was that mutation in the primer F inhibited the allele 119 bp amplification in the tumor DNA. Genotyping analyses using different combinations of primers were performed to validate this hypothesis (Figure 1) . When using the primer F containing 4 mismatches in the tumor DNA in combination with primer R or 6, a pattern of LOH of the smaller allele was reproducibly observed. In contrast, when using the primer 5 external to the primer F, an identical pattern of alleles was observed in the tumor and non-tumor DNAs.
Searching for microdeletions with the LOH method is a powerful strategy to define the smallest commonly deleted region on a chromosome. However, looking for a unique marker deleted in a tumor is subject to artifacts. As previously described, the low amount of DNA template in PCR amplification and the variability of TaqDNA polymerase terminal transferase activity can produce false-positive allelic imbalances (1) . Control of these parameters easily guarantees a good quality of genotyping. In contrast, allelic imbalance, due to a somatic allelic mutation in the sequence complementary to the primers used to genotype, is difficult to unmask. Frequency of these somatic mutations is difficult to evaluate as it is linked to the unknown rate of random mutations occurring in genomic noncoding region in tumor DNA. In our case, the occurrence of the mutation could have been promoted by a small local dinucleotide repeat (TGT-A/G-TATG). Because CHC172 has been genotyped with 400 microsatellite markers spread over the genome, and because no replication error (RER) pattern has been observed, the somatic mutation observed at the D4S430 locus does not seem to be caused by a mismatch repair defect. However, before beginning an extensive physical mapping program, false-positive LOH or homozygous deletion should be eliminated by monitoring the LOH status with different methods, such as genotyping with flanking primers, Southern blotting or sequencing focused on the loci under study. 
